Results 141 to 150 of about 60,311 (178)

Duplex Unwinding Mechanism of Coronavirus MERS-CoV nsp13 Helicase. [PDF]

Chem Biomed Imaging
Hao W, Hu X, Chen Q, Qin B, Tian Z, Li Z, Hou P, Zhao R, Balci H, Cui S, Diao J.   +10 more
europepmc   +1 more source

Recombination analysis on the receptor switching event of MERS-CoV and its close relatives: implications for the emergence of MERS-CoV. [PDF]

Virol J
Tolentino JE, Lytras S, Ito J, Sato K.
europepmc   +1 more source

Variable DPP4 expression in multiciliated cells of the human nasal epithelium as a determinant for MERS-CoV tropism. [PDF]

Proc Natl Acad Sci U S A
Breugem TI, Riesebosch S, Zhang J, Mykytyn AZ, Krabbendam L, Groen N, Baptista Varela S, Schipper D, van den Doel PB, van Acker R, Stadhouders R, Lamers MM, Haagmans BL.   +12 more
europepmc   +1 more source

Harnessing immunotherapeutic molecules and diagnostic biomarkers as human-derived adjuvants for MERS-CoV vaccine development. [PDF]

Front Immunol
Alrasheed AR, Awadalla M, Alnajran H, Alammash MH, Almaqati AM, Qadri I, Alosaimi B.   +6 more
europepmc   +1 more source

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection

Vaccine, 2017
The Middle East respiratory syndrome coronavirus (MERS-CoV) was first discovered in late 2012 and has gone on to cause over 1800 infections and 650 deaths. There are currently no approved therapeutics or vaccinations for MERS-CoV. The MERS-CoV spike (S) protein is responsible for receptor binding and virion entry to cells, is immunodominant and induces
Gregory Glenn, Christopher M Coleman, Matthew B. Frieman   +2 more
exaly   +3 more sources

Prospects for a MERS-CoV spike vaccine [PDF]

Expert Review of Vaccines, 2018
Six years have passed since Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV), a newly emerging infectious virus, was first reported in 2012. Although MERS-CoV has had a consistently high mortality rate in humans, no vaccines have been approved to prevent MERS-CoV infection in humans.
Lanying Du, Jiang Shibo
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

MERS-CoV Infection

2021
Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging pathogen associated with severe respiratory symptoms and renal failure in infected persons and mild-to-subclinical infection in dromedary camels. MERS-CoV causes nowell-defined disease in camels and its impact of MERS-CoV on animal health is exceptionally low.
openaire   +1 more source

Managing MERS-CoV in the healthcare setting

Hospital Practice, 2015
Middle East respiratory Syndrome Coronavirus (MERS-CoV) has caused at least 1118 reported cases in 24 countries with at least 423 deaths worldwide. All cases are epidemiologically linked to the Arabian Penninsula with most cases reported from the Kingdom of Saudi Arabia.
Jaffar A, Al-Tawfiq, Ziad A, Memish
openaire   +2 more sources

History of MERS-CoV

The Middle East respiratory syndrome-coronavirus (MERS-CoV) is a rising threat to the whole world’s health security. It is considered a new epidemic. It is a fatal respiratory disease with an elevated death rate. In humans, it produces low respiratory tract infections. The virus originated from bats but serological studies were conducted.
Sana Tehseen, null Sidra-Tul-Muntaha, Muhammad Saeed, Kashif Rahim, Muhammad Zeeshan Iqbal, Firasat Hussain, Umair Younas   +6 more
openaire   +1 more source